v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities      
Net (loss) income $ (92,099,000) $ (420,448,000) $ 16,870,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 82,910,000 83,858,000 81,073,000
Non-cash interest expense 1,835,000 102,000 836,000
Allowance for credit losses 2,767,000 3,202,000 3,328,000
Stock-based compensation expense 33,543,000 33,763,000 30,401,000
Foreign exchange transaction gain (1,297,000) (101,000) (1,026,000)
Change in fair value of contingent consideration 300,000 (372,000) 0
Noncash lease expense 3,179,000 3,029,000 5,661,000
Impairment of goodwill 0 336,640,000 0
(Increase) decrease in assets:      
Accounts receivable, gross 5,823,000 (19,251,000) 83,893,000
Prepaid expenses 777,000 688,000 49,000
Value-added tax receivable (3,570,000) (4,356,000) 11,911,000
Other current assets 613,000 (1,931,000) (3,953,000)
Right-of-use asset (3,928,000) (2,123,000) 0
Other non-current assets 939,000 (5,194,000) (636,000)
Increase (decrease) in liabilities:      
Accounts payable (19,345,000) 40,190,000 (48,831,000)
Accrued revenue share 1,418,000 (34,955,000) (26,002,000)
Accrued compensation 298,000 (3,552,000) (18,228,000)
Other current liabilities 2,410,000 14,335,000 (10,044,000)
Deferred income taxes (4,054,000) 6,900,000 (6,039,000)
Other non-current liabilities (639,000) (1,747,000) (5,887,000)
Net cash provided by operating activities 11,880,000 28,677,000 113,376,000
Cash flows from investing activities      
Equity investments 0 (19,634,000) (8,499,000)
Business acquisition, net of cash acquired 0 65,000 (2,708,000)
Capital expenditures (27,477,000) (24,279,000) (23,858,000)
Net cash used in investing activities (27,477,000) (43,848,000) (35,065,000)
Cash flows from financing activities      
Proceeds from borrowings 38,000,000 50,000,000 25,500,000
Payment of debt issuance costs (1,627,000) 0 (99,000)
Repayment of debt obligations (13,000,000) (77,134,000) (149,000,000)
Acquisition of non-controlling interest in consolidated subsidiaries 0 (3,751,000) 0
Payment of withholding taxes for net share settlement of equity awards (465,000) (1,286,000) (6,709,000)
Options exercised 373,000 2,871,000 2,020,000
Net cash provided by (used in) financing activities 23,281,000 (29,300,000) (128,288,000)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (1,205,000) 2,518,000 (1,627,000)
Net change in cash, cash equivalents, and restricted cash 6,479,000 (41,953,000) (51,604,000)
Cash, cash equivalents, and restricted cash, beginning of period 33,605,000 75,558,000 127,162,000
Cash, cash equivalents, and restricted cash, end of period 40,084,000 33,605,000 75,558,000
Reconciliation of cash, cash equivalents, and restricted cash      
Cash, cash equivalents, and restricted cash 39,393,000 32,916,000 75,058,000
Restricted cash 691,000 689,000 500,000
Total cash, cash equivalents and restricted cash 40,084,000 33,605,000 75,558,000
Supplemental disclosure of cash flow information      
Interest paid 35,583,000 30,716,000 20,187,000
Income taxes paid 7,150,000 1,529,000 5,658,000
Supplemental disclosure of non-cash activities      
Assets acquired not yet paid 519,000 546,000 445,000
Right-of-use assets acquired under operating leases 4,096,000 2,683,000 0
Fair value of unpaid contingent consideration in connection with business acquisitions 1,664,000 2,366,000 2,738,000
Fyber      
Supplemental disclosure of non-cash activities      
Common stock issued for the acquisition of Fyber $ 0 $ 0 $ 50,000,000